Li Zhao
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid 10
- Pharmacology top 5%
- Pharmacology top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation 5
- Molecular Biology top 10%
- Inflammasome and immune disorders 8
- Heme Oxygenase-1 and Carbon Monoxide 4
-
- Microbial Community Ecology and Physiology 5
-
- Immune Cell Function and Interaction 4
-
- Adipose Tissue and Metabolism 4
-
- Alcohol Consumption and Health Effects 4
- Co-authors
- Qi JiaYachun HanLin SunYiming LiJiye ShiKun ZouWeiliang ZhuBo Li
- Journals
- Current Medicinal Chemistry (4 papers)Scientific Reports (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Zhao
103 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Nephrology 259
- Pharmacology 127
- Pharmacology 221
- Cancer Research 169
- Molecular Biology 712
Countries citing papers authored by Li Zhao
This map shows the geographic impact of Li Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhao more than expected).
Fields of papers citing papers by Li Zhao
This network shows the impact of papers produced by Li Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhao. The network helps show where Li Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 21 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 12 | |
| 11 | 2019 | 20 | |
| 12 | 2018 | 1 | |
| 13 | 2018 | 43 | |
| 14 | 2017 | 50 | |
| 15 | 2015 | 27 | |
| 16 | 2015 | 23 | |
| 17 | 2011 | 6 | |
| 18 | 2011 | 11 | |
| 19 | Effects of a Compound Extract from Agrimonia pilosa Ledeb, Grifola umbellata (pers.) Pilat, and Gambogia on Human Gastric Carcinoma MGC-803 Cells | 2009 | 4 |
| 20 | Combined therapy with hyperbaric oxygen and anti-platelet aggregation agent for the prevention of delayed encephalopathy after acute carbon monoxide poisoning | 2002 | 1 |
About Li Zhao
Li Zhao is a scholar working on Nephrology, Geriatrics and Gerontology, Endocrine and Autonomic Systems, Complementary and alternative medicine and Cancer Research, having authored 109 papers that have together received 1.7k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (10 papers), Inflammasome and immune disorders (8 papers), Microbial Community Ecology and Physiology (5 papers), MicroRNA in disease regulation (5 papers), Immune Cell Function and Interaction (4 papers), Adipose Tissue and Metabolism (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers) and Alcohol Consumption and Health Effects (4 papers). The work is most often cited by research in Nephrology (259 citations), Pharmacology (127 citations), Pharmacology (221 citations), Cancer Research (169 citations) and Molecular Biology (712 citations). Li Zhao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qi Jia, Yachun Han, Lin Sun, Yiming Li, Jiye Shi, Kun Zou, Weiliang Zhu, Bo Li, Yong Zhang and Li Xiao. Their work appears in journals such as Current Medicinal Chemistry, Scientific Reports, Frontiers in Immunology, BMC Nephrology and Food & Function.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.